Carboplatin 450g/45mls vial 1’s

Indications:

• Ovarian cancer (both initial treatment and relapsed disease).
• Lung cancer (non-small cell and small cell).
• Head and neck cancers.
• Sometimes used in bladder, breast, and other solid tumors as part of combination chemotherapy.

Administration:

• Supplied as a ready-to-use solution for intravenous infusion.
• Given by slow IV infusion under the supervision of a qualified healthcare professional.
• Dose is usually calculated based on the patient’s kidney function (glomerular filtration rate) and body surface area.
• Treatment is administered in cycles, often every 3 to 4 weeks, depending on the cancer type and protocol.

Safety Information:

• Contraindicated in patients with severe bone marrow suppression or allergy to carboplatin or other platinum-containing drugs.
• Inform your doctor if you have kidney problems, hearing difficulties, prior chemotherapy, or low blood counts.
• Common side effects: nausea, vomiting, fatigue, low blood counts (anemia, neutropenia, thrombocytopenia), and temporary taste changes.
• Possible serious effects: infections due to low immunity, bleeding problems, kidney toxicity, hearing loss (ototoxicity), and allergic reactions.
• Requires regular blood tests and sometimes kidney function and hearing tests during treatment.

Notice:
Carboplatin 450mg/45ml Vial is a prescription-only chemotherapy medicine. It must be administered only by oncology healthcare professionals in a hospital or specialized cancer treatment center.